Last reviewed · How we verify
Swallowed fluticasone
At a glance
| Generic name | Swallowed fluticasone |
|---|---|
| Sponsor | Walter Reed Army Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children
- Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE (PHASE2)
- Evaluating Adrenal Insufficiency in Adults With Eosinophilic Esophagitis on Chronic Swallowed Topical Steroids
- A Study of Flovent in Patients With Eosinophilic Esophagitis (PHASE2)
- SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study (PHASE2, PHASE3)
- EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone (PHASE4)
- Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids (PHASE2, PHASE3)
- A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Swallowed fluticasone CI brief — competitive landscape report
- Swallowed fluticasone updates RSS · CI watch RSS
- Walter Reed Army Medical Center portfolio CI